Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergy

[...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was signific...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 142; no. 1; pp. 335 - 338.e9
Main Authors Lee-Sarwar, Kathleen, Kelly, Rachel S., Lasky-Su, Jessica, Moody, D. Branch, Mola, Alex R., Cheng, Tan-Yun, Comstock, Laurie E., Zeiger, Robert S., O'Connor, George T., Sandel, Megan T., Bacharier, Leonard B., Beigelman, Avraham, Laranjo, Nancy, Gold, Diane R., Bunyavanich, Supinda, Savage, Jessica H., Weiss, Scott T., Brennan, Patrick J., Litonjua, Augusto A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2018
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was significantly lower among subjects born by Cesarean section than among subjects born by vaginal delivery (P = .049). Asthma or recurrent wheeze was based on parental report of physician diagnosis of asthma or recurrent wheeze in the first 3 years of life as previously reported.4 Questionnaire responses were used to determine whether a child was ingesting breast milk and/or formula, and whether solid foods had been introduced at the time of stool sample collection as previously described.E1Fecal sample collection and profiling Stool collection and microbiome profiling methods have been described in detail previously.E2 DNA extraction was performed on the stool samples and sequencing of the bacterial 16S V3 to V5 hypervariable regions was performed by pyrosequencing (Roche 454 Titanium platform) at the Genome Center (TGI) at Washington University in St Louis, Mo. Subject Food Reaction∗ Age (mo) reported Diagnosis method Serum specific IgE (kU/L) Walnut Peanut Egg white Milk Wheat Soybean 1 Sesame seed Unknown 24 Blood and skin test <0.10 1.00 5.42 0.67 0.42 0.63 Egg Unknown 24 Other nut Unknown 24 Peanut Rash 24 2 Soy Diarrhea, nausea, hives 12 Blood and skin test <0.10 2.05 22.4 1.9 0.65 1.27 Wheat Diarrhea, nausea, hives 12 Peanut Diarrhea, nausea, hives 12 Egg Diarrhea, nausea, hives 12 Other nut Unknown 15 Fish Diarrhea, nausea, hives 24 3 Milk Hives, nausea, wheeze, worsened eczema 12 Blood test and skin test 3.05 8.72 5.03 9.88 5.06 3.89 Egg Nausea, vomiting, wheeze, sneezing/runny nose, watery eyes, hives, worsened eczema, fatigue 12 Peanut Nausea 12 Other fish Hives, nausea, diarrhea, worsened eczema, facial swelling, fussiness 12 Soy Hives, fussiness, vaginal itching, nausea, diarrhea 18 Shellfish Facial swelling, hives, worsened eczema, fussiness, nausea, diarrhea 18 Wheat Hives, fussiness, vaginal itching, nausea 21 4 Shellfish Hives, worsened eczema, nausea 12 Blood test and skin test 5.03 1.33 0.53 <0.10 0.38 0.28 Other fish Hives, worsened eczema, nausea 12 Egg Hives, wheeze, worsened eczema, nausea 12 Hot dog Hives 15 Milk Hives, worsened eczema, nausea 24 Wheat Hives 24 Peanut Hives, worsened eczema, nausea 27 5 Egg Nausea, hives, fatigue 18 Skin test 0.66 1.32 1.59 4.24 0.78 2.28 6 Peanut Hives, wheezing, sneezing, red eyes 24 History 12.7 >100 38.5 26 29 96.3 7 Other nut Eyes swelled shut, itchy 36 Skin test 0.72 2.07 4.41 8.51 1.95 0.96 8 Unknown Unknown 15 Blood test 0.25 >100 0.71 <0.10 0.15 2.2 Peanut Hives 24 9 Peanut Hives on 1 body part only 15 Blood and skin test 1.54 9.76 5.67 0.94 2.07 2.96 Egg Nausea, hives 15 Pea Hives on 1 body part only 24 Lentil Hives on 1 body part only 24 Other nut Unknown 30 10 Peanut Not asked† 12 Not asked† <0.10 0.79 0.43 0.25 0.27 <0.10 Egg Not asked† 12 11 Egg Not asked† 12 Not asked† <0.10 <0.10 0.62 <0.10 <0.10 <0.10 12 Egg Hives on 1 body part only, nausea, cough 27 Blood test <0.10 0.37 3.75 1.88 0.90 0.91 Candy/sweets Nausea 36 Table E1 Clinical history and serum specific IgE for food-allergic subjects Characteristic All children (n = 81) All subjects (n = 83) Subjects with iNKT-cell activity data (n = 57) Food allergic (n = 12) Food sensitive (n = 32) Control (n = 37) P value Food allergic (n = 8) Food sensitive (n = 22) Control (n = 27) P value Sex, n (%) .66 .17 Male 41 (51) 5 (42) 18 (56) 18 (49) 2 (25) 14 (64) 13 (48) Female 40 (49) 7 (58) 14 (44) 19 (51) 6 (75) 8 (36) 14 (52) Race/ethnicity, n (%) .94 .98 Black, non-Hispanic 34 (42) 6 (50) 13 (41) 15 (41) 4 (50) 9 (41) 10 (37) White, non-Hispanic 26 (32) 4 (33) 11 (34) 11 (30) 2 (25) 6 (27) 9 (33) Hispanic 21 (26) 2 (17) 8 (25) 11 (30) 2 (25) 7 (32) 8 (30) Birth by Cesarean section, n (%) 24 (30) 6 (50) 5 (16) 13 (35) .052 5 (63) 2 (9) 9 (33) .01 Gestational age (wk), mean ± SD 39.1 ± 1.6 39.4 ± 1.7 38.9 ± 1.9 39.4 ± 1.4 .48 39.3 ± 1.6 38.8 ± 2.2 39.4 ± 1.4 .79 Number of living children born to mother, mean ± SD 0.9 ± 0.9 1.2 ± 0.9 1.0 ± 0.9 0.8 ± 0.9 .40 1.3 ± 0.9 0.8 ± 0.8 0.8 ± 0.9 .36 Antibiotic exposure, n (%) Perinatal antibiotics 35 (43) 8 (67) 11 (34) 16 (43) .16 5 (63) 8 (36) 11 (41) .44 By age 6 mo 15 (19) 2 (17) 5 (16) 8 (22) .86 1 (13) 3 (14) 7 (26) .59 By age 3 y 69 (85) 11 (92) 29 (91) 29 (78) .36 7 (87) 21 (95) 20 (74) .10 Pet dog in home, n (%) In first 6 mo of life 22 (28) 3 (33) 6 (19) 13 (36) .31 2 (25) 3 (14) 10 (37) .19 Between age 6 and 36 mo 32 (41) 3 (33) 13 (43) 16 (43) .52 2 (25) 10 (50) 11 (41) .53 Pet cat in home, n (%) In first 6 mo of life 11 (14) 2 (17) 4 (13) 5 (14) .91 1 (13) 2 (9) 4 (15) .86 Between age 6 and 36 mo 20 (25) 6 (50) 5 (17) 9 (24) .10 3 (38) 2 (10) 6 (22) .22 Daycare by age 3 y, n (%) 43 (53) 7 (58) 15 (47) 21 (57) .72 4 (50) 10 (45) 14 (52) .93 Age at stool sample collection (mo), mean ± SD 4.6 ± 1.1 5.0 ± 1.0 5.0 ± 1.0 4.1 ± 1.0 <.01 5.0 ± 1.0 5.1 ± 1.0 4.2 ± 1.1 .02 Diet at stool sample collection, n (%) Breast-feeding 34 (42) 6 (50) 13 (41) 15 (41) .91 4 (50) 7 (32) 12 (44) .57 Formula 50 (62) 7 (58) 20 (63) 23 (62) 1 4 (50) 16 (73) 17 (63) .51 Solid foods 33 (41) 6 (50) 19 (61) 8 (22) <.01 4 (50) 12 (57) 7 (26) .07 Asthma/recurrent wheeze by age 3 y, n (%) 25 (31) 8 (67) 9 (28) 8 (22) .02 6 (75) 7 (32) 4 (15) <.01 VDAART treatment group, n (%) 1 1 4400 IU/d vitamin D 41 (51) 6 (50) 16 (50) 19 (51) 4 (50) 11 (50) 13 (48) 400 IU/d vitamin D 40 (49) 6 (50) 16 (50) 18 (49) 4 (50) 11 (50) 14 (52) Study center, n (%) .27 .71 Boston 23 (28) 4 (33) 8 (25) 11 (30) 1 (13) 2 (9) 7 (26) St Louis 42 (52) 7 (58) 20 (63) 15 (41) 3 (38) 7 (32) 9 (33) San Diego 16 (20) 1 (8) 4 (13) 11 (30) 4 (50) 13 (59) 11 (41) Maternal education, n (%) .92 .74 Less than high school 10 (12) 1 (8) 3 (9) 6 (16) 0 (0) 3 (14) 4 (15) High school or technical school 26 (32) 5 (42) 11 (34) 10 (27) 4 (50) 8 (36) 6 (22) Some college 10 (12) 2 (17) 4 (13) 4 (11) 1 (13) 3 (14) 3 (11) College graduate or graduate school 35 (43) 4 (33) 14 (44) 17 (46) 3 (38) 8 (36) 14 (52) Household income (US $), n (%) .57 .55 <30,000 29 (36) 6 (50) 12 (38) 11 (30) 5 (63) 8 (36) 8 (30) 30,000-49,999 11 (14) 1 (8) 5 (16) 5 (14) 0 (0) 4 (18) 4 (15) 50,000-74,999 9 (11) 1 (8) 3 (9) 5 (14) 1 (13) 3 (14) 4 (15) 75,000-99,999 8 (10) 1 (8) 1 (3) 6 (16) 1 (13) 0 (0) 4 (15) 100,000-149,999 10 (12) 2 (17) 2 (6) 6 (16) 1 (13) 1 (5) 4 (15) At least 150,000 5 (6) 0 (0) 4 (13) 1 (3) 0 (0) 2 (9) 1 (4) Refused to say or unknown 9 (11) 1 (8) 5 (16) 3 (8) 0 (0) 4 (18) 2 (7) Table E2 Baseline characteristics of children and upstream predictors of the intestinal microenvironment Food-allergic (n = 12) vs control (n = 37, reference) Food-sensitive (n = 32) vs control (n = 37, reference) Food-allergic (n = 12) vs food-sensitive (n = 32, reference) Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value 7-Methylguanine 0.29 (0.11-0.63) .004 3-Ketosphinganine 2.49 (1.37-4.89) .004 3-Hydroxypalmitate 0.23 (0.07-0.59) .01 Docosapentaenoate (n3 DPA; 22:5n3) 0.24 (0.07-0.64) .01 Pimelate (heptanedioate) 2.83 (1.38-6.29) .01 Ribonate 0.32 (0.13-0.69) .01 2-Aminophenol 3.20 (1.40-8.68) .01 Pyridoxine (vitamin B6) 3.08 (1.40-7.63) .01 1-Palmitoyl-GPI (16:0) 0.25 (0.08-0.63) .01 Bilirubin (E,Z or Z,E)∗ 0.20 (0.05-0.62) .01 Cis-urocanate 0.24 (0.07-0.66) .01 1-Palmitoyl-GPS (16:0)∗ 0.25 (0.08-0.65) .01 Histidine 0.11 (0.01-0.53) .01 Diacetylchitobiose 0.38 (0.16, -0.79) .01 I-urobilinogen 0.42 (0.20-0.79) .01 N-formylmethionine 0.28 (0.09-0.72) .01 N-acetylglutamate 0.25 (0.07-0.73) .02 Sphinganine 0.15 (0.03-0.56) .01 I-urobilinogen 0.43 (0.20-0.82) .02 5alpha-pregnan-3beta,20alpha-diol monosulfate (1) 3.04 (1.31-8.77) .02 2-Methylserine 0.32 (0.11-0.75) .02 Dihomo-linolenate (20:3n3 or n6) 0.25 (0.06-0.66) .02 N-carbamoylaspartate 0.38 (0.15-0.81) .02 13-Methylmyristate 0.39 (0.17-0.82) .02 Serine 0.11 (0.01-0.59) .02 N-acetylasparagine 0.26 (0.08-0.78) .02 Dihomo-linolenate (20:3n3 or n6) 0.24 (0.06-0.67) .02 2-Methylserine 0.20 (0.04-0.68) .03 Lysylleucine 2.23 (1.15-4.69) .02 Glycylisoleucine 0.25 (0.07-0.70) .02 5,6-Dihydrothymine 0.40 (0.16-0.86) .03 Vanillic alcohol sulfate 0.42 (0.18-0.86) .03 D-urobilin 0.40 (0.17-0.83) .02 3-Hydroxypalmitate 0.27 (0.07-0.79) .03 Docosahexenoylcarnitine (C22:6)∗ 0.37 (0.14-0.83) .03 Docosapentaenoate (n3 DPA; 22:5n3) 0.26 (0.07-0.74) .02 Phenethylamine 0.32 (0.10-0.83) .03 Ursodeoxycholate sulfate (1) 0.57 (0.34-0.92) .03 7-Methylguanine 0.47 (0.23-0.90) .03 D-urobilin 0.42 (0.18-0.91) .04 3-Methylglutarate/2-methylglutarate 2.35 (1.14-5.35) .03 Sucrose 0.37 (0.14-0.85) .03 Ursodeoxycholate sulfate (1) 0.45 (0.20-0.90) .04 N-palmitoylserine 1.87 (1.08-3.36) .03 1-Palmitoyl-GPE (16:0) 0.20 (0.04-0.73) .03 Tryptamine 0.44 (0.19-0.90) .04 Malonylcarnitine 0.39 (0.16-0.87) .03 21-Hydroxypregnenolone disulfate 0.31 (0.09-0.80) .03 2,3-Dimethylsuccinate 3.06 (1.09-9.72) .04 13-Methylmyristate 1.97 (1.08-3.80) .03 N-acetylglycine 3.33 (1.21-11.18) .03 Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] 2.56 (1.09-6.94) .04 Dopamine 3-O-sulfate 0.45 (0.21-0.90) .03 Alpha-CEHC 0.32 (0.10-0.840) .03 Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1]∗ 2.56 (1.08-7.07) .04 Glutaminylleucine 2.58 (1.12-6.57) .03 Glycerophosphoserine∗ 0.28 (0.08-0.82) .03 Tyrosine 0.16 (0.02-0.86) .04 N2,N6-diacetyllysine 0.41 (0.17-0.90) .03 Bilirubin (E,Z or Z,E)∗ 0.32 (0.10-0.87) .04 Formiminoglutamate 0.36 (0.11-0.90) .04 N-acetyl-aspartyl-glutamate (NAAG) 0.41 (0.17-0.91) .04 Glycylvaline 0.24 (0.05-0.87) .04 Linolenate (alpha or gamma; [18:3n3 or 6]) 0.27 (0.06-0.86) .04 N-alpha-acetylornithine 0.39 (0.15-0.91) .04 Linoleoyl ethanolamide 0.42 (0.17-0.94) .04 Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2]∗ 2.39 (1.04-6.06) .05 Allo-threonine 0.40 (0.15-0.90) .04 3-Ureidoisobutyrate 0.45 (
AbstractList [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was significantly lower among subjects born by Cesarean section than among subjects born by vaginal delivery (P = .049). Asthma or recurrent wheeze was based on parental report of physician diagnosis of asthma or recurrent wheeze in the first 3 years of life as previously reported.4 Questionnaire responses were used to determine whether a child was ingesting breast milk and/or formula, and whether solid foods had been introduced at the time of stool sample collection as previously described.E1Fecal sample collection and profiling Stool collection and microbiome profiling methods have been described in detail previously.E2 DNA extraction was performed on the stool samples and sequencing of the bacterial 16S V3 to V5 hypervariable regions was performed by pyrosequencing (Roche 454 Titanium platform) at the Genome Center (TGI) at Washington University in St Louis, Mo. Subject Food Reaction∗ Age (mo) reported Diagnosis method Serum specific IgE (kU/L) Walnut Peanut Egg white Milk Wheat Soybean 1 Sesame seed Unknown 24 Blood and skin test <0.10 1.00 5.42 0.67 0.42 0.63 Egg Unknown 24 Other nut Unknown 24 Peanut Rash 24 2 Soy Diarrhea, nausea, hives 12 Blood and skin test <0.10 2.05 22.4 1.9 0.65 1.27 Wheat Diarrhea, nausea, hives 12 Peanut Diarrhea, nausea, hives 12 Egg Diarrhea, nausea, hives 12 Other nut Unknown 15 Fish Diarrhea, nausea, hives 24 3 Milk Hives, nausea, wheeze, worsened eczema 12 Blood test and skin test 3.05 8.72 5.03 9.88 5.06 3.89 Egg Nausea, vomiting, wheeze, sneezing/runny nose, watery eyes, hives, worsened eczema, fatigue 12 Peanut Nausea 12 Other fish Hives, nausea, diarrhea, worsened eczema, facial swelling, fussiness 12 Soy Hives, fussiness, vaginal itching, nausea, diarrhea 18 Shellfish Facial swelling, hives, worsened eczema, fussiness, nausea, diarrhea 18 Wheat Hives, fussiness, vaginal itching, nausea 21 4 Shellfish Hives, worsened eczema, nausea 12 Blood test and skin test 5.03 1.33 0.53 <0.10 0.38 0.28 Other fish Hives, worsened eczema, nausea 12 Egg Hives, wheeze, worsened eczema, nausea 12 Hot dog Hives 15 Milk Hives, worsened eczema, nausea 24 Wheat Hives 24 Peanut Hives, worsened eczema, nausea 27 5 Egg Nausea, hives, fatigue 18 Skin test 0.66 1.32 1.59 4.24 0.78 2.28 6 Peanut Hives, wheezing, sneezing, red eyes 24 History 12.7 >100 38.5 26 29 96.3 7 Other nut Eyes swelled shut, itchy 36 Skin test 0.72 2.07 4.41 8.51 1.95 0.96 8 Unknown Unknown 15 Blood test 0.25 >100 0.71 <0.10 0.15 2.2 Peanut Hives 24 9 Peanut Hives on 1 body part only 15 Blood and skin test 1.54 9.76 5.67 0.94 2.07 2.96 Egg Nausea, hives 15 Pea Hives on 1 body part only 24 Lentil Hives on 1 body part only 24 Other nut Unknown 30 10 Peanut Not asked† 12 Not asked† <0.10 0.79 0.43 0.25 0.27 <0.10 Egg Not asked† 12 11 Egg Not asked† 12 Not asked† <0.10 <0.10 0.62 <0.10 <0.10 <0.10 12 Egg Hives on 1 body part only, nausea, cough 27 Blood test <0.10 0.37 3.75 1.88 0.90 0.91 Candy/sweets Nausea 36 Table E1 Clinical history and serum specific IgE for food-allergic subjects Characteristic All children (n = 81) All subjects (n = 83) Subjects with iNKT-cell activity data (n = 57) Food allergic (n = 12) Food sensitive (n = 32) Control (n = 37) P value Food allergic (n = 8) Food sensitive (n = 22) Control (n = 27) P value Sex, n (%) .66 .17 Male 41 (51) 5 (42) 18 (56) 18 (49) 2 (25) 14 (64) 13 (48) Female 40 (49) 7 (58) 14 (44) 19 (51) 6 (75) 8 (36) 14 (52) Race/ethnicity, n (%) .94 .98 Black, non-Hispanic 34 (42) 6 (50) 13 (41) 15 (41) 4 (50) 9 (41) 10 (37) White, non-Hispanic 26 (32) 4 (33) 11 (34) 11 (30) 2 (25) 6 (27) 9 (33) Hispanic 21 (26) 2 (17) 8 (25) 11 (30) 2 (25) 7 (32) 8 (30) Birth by Cesarean section, n (%) 24 (30) 6 (50) 5 (16) 13 (35) .052 5 (63) 2 (9) 9 (33) .01 Gestational age (wk), mean ± SD 39.1 ± 1.6 39.4 ± 1.7 38.9 ± 1.9 39.4 ± 1.4 .48 39.3 ± 1.6 38.8 ± 2.2 39.4 ± 1.4 .79 Number of living children born to mother, mean ± SD 0.9 ± 0.9 1.2 ± 0.9 1.0 ± 0.9 0.8 ± 0.9 .40 1.3 ± 0.9 0.8 ± 0.8 0.8 ± 0.9 .36 Antibiotic exposure, n (%) Perinatal antibiotics 35 (43) 8 (67) 11 (34) 16 (43) .16 5 (63) 8 (36) 11 (41) .44 By age 6 mo 15 (19) 2 (17) 5 (16) 8 (22) .86 1 (13) 3 (14) 7 (26) .59 By age 3 y 69 (85) 11 (92) 29 (91) 29 (78) .36 7 (87) 21 (95) 20 (74) .10 Pet dog in home, n (%) In first 6 mo of life 22 (28) 3 (33) 6 (19) 13 (36) .31 2 (25) 3 (14) 10 (37) .19 Between age 6 and 36 mo 32 (41) 3 (33) 13 (43) 16 (43) .52 2 (25) 10 (50) 11 (41) .53 Pet cat in home, n (%) In first 6 mo of life 11 (14) 2 (17) 4 (13) 5 (14) .91 1 (13) 2 (9) 4 (15) .86 Between age 6 and 36 mo 20 (25) 6 (50) 5 (17) 9 (24) .10 3 (38) 2 (10) 6 (22) .22 Daycare by age 3 y, n (%) 43 (53) 7 (58) 15 (47) 21 (57) .72 4 (50) 10 (45) 14 (52) .93 Age at stool sample collection (mo), mean ± SD 4.6 ± 1.1 5.0 ± 1.0 5.0 ± 1.0 4.1 ± 1.0 <.01 5.0 ± 1.0 5.1 ± 1.0 4.2 ± 1.1 .02 Diet at stool sample collection, n (%) Breast-feeding 34 (42) 6 (50) 13 (41) 15 (41) .91 4 (50) 7 (32) 12 (44) .57 Formula 50 (62) 7 (58) 20 (63) 23 (62) 1 4 (50) 16 (73) 17 (63) .51 Solid foods 33 (41) 6 (50) 19 (61) 8 (22) <.01 4 (50) 12 (57) 7 (26) .07 Asthma/recurrent wheeze by age 3 y, n (%) 25 (31) 8 (67) 9 (28) 8 (22) .02 6 (75) 7 (32) 4 (15) <.01 VDAART treatment group, n (%) 1 1 4400 IU/d vitamin D 41 (51) 6 (50) 16 (50) 19 (51) 4 (50) 11 (50) 13 (48) 400 IU/d vitamin D 40 (49) 6 (50) 16 (50) 18 (49) 4 (50) 11 (50) 14 (52) Study center, n (%) .27 .71 Boston 23 (28) 4 (33) 8 (25) 11 (30) 1 (13) 2 (9) 7 (26) St Louis 42 (52) 7 (58) 20 (63) 15 (41) 3 (38) 7 (32) 9 (33) San Diego 16 (20) 1 (8) 4 (13) 11 (30) 4 (50) 13 (59) 11 (41) Maternal education, n (%) .92 .74 Less than high school 10 (12) 1 (8) 3 (9) 6 (16) 0 (0) 3 (14) 4 (15) High school or technical school 26 (32) 5 (42) 11 (34) 10 (27) 4 (50) 8 (36) 6 (22) Some college 10 (12) 2 (17) 4 (13) 4 (11) 1 (13) 3 (14) 3 (11) College graduate or graduate school 35 (43) 4 (33) 14 (44) 17 (46) 3 (38) 8 (36) 14 (52) Household income (US $), n (%) .57 .55 <30,000 29 (36) 6 (50) 12 (38) 11 (30) 5 (63) 8 (36) 8 (30) 30,000-49,999 11 (14) 1 (8) 5 (16) 5 (14) 0 (0) 4 (18) 4 (15) 50,000-74,999 9 (11) 1 (8) 3 (9) 5 (14) 1 (13) 3 (14) 4 (15) 75,000-99,999 8 (10) 1 (8) 1 (3) 6 (16) 1 (13) 0 (0) 4 (15) 100,000-149,999 10 (12) 2 (17) 2 (6) 6 (16) 1 (13) 1 (5) 4 (15) At least 150,000 5 (6) 0 (0) 4 (13) 1 (3) 0 (0) 2 (9) 1 (4) Refused to say or unknown 9 (11) 1 (8) 5 (16) 3 (8) 0 (0) 4 (18) 2 (7) Table E2 Baseline characteristics of children and upstream predictors of the intestinal microenvironment Food-allergic (n = 12) vs control (n = 37, reference) Food-sensitive (n = 32) vs control (n = 37, reference) Food-allergic (n = 12) vs food-sensitive (n = 32, reference) Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value 7-Methylguanine 0.29 (0.11-0.63) .004 3-Ketosphinganine 2.49 (1.37-4.89) .004 3-Hydroxypalmitate 0.23 (0.07-0.59) .01 Docosapentaenoate (n3 DPA; 22:5n3) 0.24 (0.07-0.64) .01 Pimelate (heptanedioate) 2.83 (1.38-6.29) .01 Ribonate 0.32 (0.13-0.69) .01 2-Aminophenol 3.20 (1.40-8.68) .01 Pyridoxine (vitamin B6) 3.08 (1.40-7.63) .01 1-Palmitoyl-GPI (16:0) 0.25 (0.08-0.63) .01 Bilirubin (E,Z or Z,E)∗ 0.20 (0.05-0.62) .01 Cis-urocanate 0.24 (0.07-0.66) .01 1-Palmitoyl-GPS (16:0)∗ 0.25 (0.08-0.65) .01 Histidine 0.11 (0.01-0.53) .01 Diacetylchitobiose 0.38 (0.16, -0.79) .01 I-urobilinogen 0.42 (0.20-0.79) .01 N-formylmethionine 0.28 (0.09-0.72) .01 N-acetylglutamate 0.25 (0.07-0.73) .02 Sphinganine 0.15 (0.03-0.56) .01 I-urobilinogen 0.43 (0.20-0.82) .02 5alpha-pregnan-3beta,20alpha-diol monosulfate (1) 3.04 (1.31-8.77) .02 2-Methylserine 0.32 (0.11-0.75) .02 Dihomo-linolenate (20:3n3 or n6) 0.25 (0.06-0.66) .02 N-carbamoylaspartate 0.38 (0.15-0.81) .02 13-Methylmyristate 0.39 (0.17-0.82) .02 Serine 0.11 (0.01-0.59) .02 N-acetylasparagine 0.26 (0.08-0.78) .02 Dihomo-linolenate (20:3n3 or n6) 0.24 (0.06-0.67) .02 2-Methylserine 0.20 (0.04-0.68) .03 Lysylleucine 2.23 (1.15-4.69) .02 Glycylisoleucine 0.25 (0.07-0.70) .02 5,6-Dihydrothymine 0.40 (0.16-0.86) .03 Vanillic alcohol sulfate 0.42 (0.18-0.86) .03 D-urobilin 0.40 (0.17-0.83) .02 3-Hydroxypalmitate 0.27 (0.07-0.79) .03 Docosahexenoylcarnitine (C22:6)∗ 0.37 (0.14-0.83) .03 Docosapentaenoate (n3 DPA; 22:5n3) 0.26 (0.07-0.74) .02 Phenethylamine 0.32 (0.10-0.83) .03 Ursodeoxycholate sulfate (1) 0.57 (0.34-0.92) .03 7-Methylguanine 0.47 (0.23-0.90) .03 D-urobilin 0.42 (0.18-0.91) .04 3-Methylglutarate/2-methylglutarate 2.35 (1.14-5.35) .03 Sucrose 0.37 (0.14-0.85) .03 Ursodeoxycholate sulfate (1) 0.45 (0.20-0.90) .04 N-palmitoylserine 1.87 (1.08-3.36) .03 1-Palmitoyl-GPE (16:0) 0.20 (0.04-0.73) .03 Tryptamine 0.44 (0.19-0.90) .04 Malonylcarnitine 0.39 (0.16-0.87) .03 21-Hydroxypregnenolone disulfate 0.31 (0.09-0.80) .03 2,3-Dimethylsuccinate 3.06 (1.09-9.72) .04 13-Methylmyristate 1.97 (1.08-3.80) .03 N-acetylglycine 3.33 (1.21-11.18) .03 Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] 2.56 (1.09-6.94) .04 Dopamine 3-O-sulfate 0.45 (0.21-0.90) .03 Alpha-CEHC 0.32 (0.10-0.840) .03 Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1]∗ 2.56 (1.08-7.07) .04 Glutaminylleucine 2.58 (1.12-6.57) .03 Glycerophosphoserine∗ 0.28 (0.08-0.82) .03 Tyrosine 0.16 (0.02-0.86) .04 N2,N6-diacetyllysine 0.41 (0.17-0.90) .03 Bilirubin (E,Z or Z,E)∗ 0.32 (0.10-0.87) .04 Formiminoglutamate 0.36 (0.11-0.90) .04 N-acetyl-aspartyl-glutamate (NAAG) 0.41 (0.17-0.91) .04 Glycylvaline 0.24 (0.05-0.87) .04 Linolenate (alpha or gamma; [18:3n3 or 6]) 0.27 (0.06-0.86) .04 N-alpha-acetylornithine 0.39 (0.15-0.91) .04 Linoleoyl ethanolamide 0.42 (0.17-0.94) .04 Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2]∗ 2.39 (1.04-6.06) .05 Allo-threonine 0.40 (0.15-0.90) .04 3-Ureidoisobutyrate 0.45 (
Author Zeiger, Robert S.
Beigelman, Avraham
Laranjo, Nancy
O'Connor, George T.
Lee-Sarwar, Kathleen
Brennan, Patrick J.
Moody, D. Branch
Bunyavanich, Supinda
Bacharier, Leonard B.
Kelly, Rachel S.
Cheng, Tan-Yun
Gold, Diane R.
Savage, Jessica H.
Weiss, Scott T.
Sandel, Megan T.
Lasky-Su, Jessica
Litonjua, Augusto A.
Mola, Alex R.
Comstock, Laurie E.
AuthorAffiliation a Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
c Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
e Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass
h Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass
i Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
d Kaiser Permanente Southern California, San Diego, Calif
g Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children’s Hospital, St Louis, Mo
b Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
f Department of Pediatrics, Boston Medical Center, Boston, Mass
AuthorAffiliation_xml – name: h Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass
– name: g Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children’s Hospital, St Louis, Mo
– name: i Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
– name: f Department of Pediatrics, Boston Medical Center, Boston, Mass
– name: b Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
– name: a Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
– name: e Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass
– name: d Kaiser Permanente Southern California, San Diego, Calif
– name: c Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
Author_xml – sequence: 1
  givenname: Kathleen
  surname: Lee-Sarwar
  fullname: Lee-Sarwar, Kathleen
  email: klee-sarwar@partners.org
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 2
  givenname: Rachel S.
  surname: Kelly
  fullname: Kelly, Rachel S.
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 3
  givenname: Jessica
  surname: Lasky-Su
  fullname: Lasky-Su, Jessica
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 4
  givenname: D. Branch
  surname: Moody
  fullname: Moody, D. Branch
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 5
  givenname: Alex R.
  surname: Mola
  fullname: Mola, Alex R.
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 6
  givenname: Tan-Yun
  surname: Cheng
  fullname: Cheng, Tan-Yun
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 7
  givenname: Laurie E.
  surname: Comstock
  fullname: Comstock, Laurie E.
  organization: Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 8
  givenname: Robert S.
  surname: Zeiger
  fullname: Zeiger, Robert S.
  organization: Kaiser Permanente Southern California, San Diego, Calif
– sequence: 9
  givenname: George T.
  surname: O'Connor
  fullname: O'Connor, George T.
  organization: Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass
– sequence: 10
  givenname: Megan T.
  surname: Sandel
  fullname: Sandel, Megan T.
  organization: Department of Pediatrics, Boston Medical Center, Boston, Mass
– sequence: 11
  givenname: Leonard B.
  surname: Bacharier
  fullname: Bacharier, Leonard B.
  organization: Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo
– sequence: 12
  givenname: Avraham
  surname: Beigelman
  fullname: Beigelman, Avraham
  organization: Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo
– sequence: 13
  givenname: Nancy
  surname: Laranjo
  fullname: Laranjo, Nancy
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 14
  givenname: Diane R.
  surname: Gold
  fullname: Gold, Diane R.
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 15
  givenname: Supinda
  surname: Bunyavanich
  fullname: Bunyavanich, Supinda
  organization: Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
– sequence: 16
  givenname: Jessica H.
  surname: Savage
  fullname: Savage, Jessica H.
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 17
  givenname: Scott T.
  surname: Weiss
  fullname: Weiss, Scott T.
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 18
  givenname: Patrick J.
  surname: Brennan
  fullname: Brennan, Patrick J.
  organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
– sequence: 19
  givenname: Augusto A.
  surname: Litonjua
  fullname: Litonjua, Augusto A.
  email: augusto_litonjua@urmc.rochester.edu
  organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29729303$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhS1URKeFP8ACRWLDJsGvvBBCQhW0lSqxgbXlODeTGzz2YGcGzb_HYVoEsygbW74-39XRORfkzHkHhLxktGCUVW-nYtIGC05ZU1BZpNETsmK0rfOq4eUZWVHasryqZXtOLmKcaHqLpn1Gznlb81ZQsSLq1s0QZ3TaZhs0wXeobd5DwD30WdyO6Nbe4hb7mOkAGbo9hAj2kOkYvUE9J9lPnMfMjGj70fs-G5ZDWwthfXhOng7aRnhxf1-Sb58_fb26ye--XN9efbzLjWzpnEx2uq0HKrnpKk55WfemalmrKQBIgLIqDYeGQsVYDaIRUjRdV0oQFWVDx8Ul-XDcu911G-gNuDloq7YBNzoclNeo_v1xOKq136tKCsF4mRa8uV8Q_I9dikRtMBqwVjvwu6g4FSWXdcNEkr4-kU5-F1KCi6oSnDP-W_Xqb0d_rDxknwTNUZBSjzHAoAzOeka_GESrGFVLzWpSS81qqVlRqdIoofwEfdj-KPT-CEHqYY8QVDQIzkCPAcyseo-P4-9OcGPRodH2Oxz-B_8C36nV5Q
CitedBy_id crossref_primary_10_3389_fimmu_2022_972103
crossref_primary_10_1097_MOP_0000000000000806
crossref_primary_10_1053_j_gastro_2021_03_016
crossref_primary_10_1016_j_immuni_2020_07_025
crossref_primary_10_1111_all_16005
crossref_primary_10_1016_j_jfca_2024_106815
crossref_primary_10_1016_j_ajcnut_2024_11_011
crossref_primary_10_26599_FSHW_2024_9250044
crossref_primary_10_1111_all_16429
crossref_primary_10_1128_spectrum_00634_21
crossref_primary_10_1080_1744666X_2022_2101450
crossref_primary_10_26599_FSHW_2023_9250049
crossref_primary_10_1016_j_clim_2024_109928
crossref_primary_10_1128_Spectrum_00859_21
crossref_primary_10_1016_j_chom_2019_04_002
crossref_primary_10_1016_j_jaci_2020_01_012
crossref_primary_10_1016_j_anai_2018_12_012
crossref_primary_10_3389_falgy_2021_675557
crossref_primary_10_3389_fnut_2022_935711
crossref_primary_10_1016_j_anai_2019_09_017
crossref_primary_10_1111_nyas_14654
crossref_primary_10_1111_pai_14267
crossref_primary_10_1111_all_13563
crossref_primary_10_1111_all_15960
crossref_primary_10_1002_clt2_12339
crossref_primary_10_1016_j_jaci_2024_02_024
crossref_primary_10_1111_all_15602
crossref_primary_10_3390_nu14235155
crossref_primary_10_1007_s43393_024_00306_3
crossref_primary_10_1021_acs_jafc_4c05373
crossref_primary_10_1111_cea_14517
crossref_primary_10_3390_foods11213454
crossref_primary_10_1002_mnfr_202100536
crossref_primary_10_1016_j_jaci_2019_10_019
crossref_primary_10_1016_j_aninu_2020_05_007
crossref_primary_10_3390_app15062940
crossref_primary_10_1111_pai_13042
crossref_primary_10_1016_j_jaci_2019_10_014
crossref_primary_10_1111_pai_14133
crossref_primary_10_1016_j_jaip_2020_07_044
crossref_primary_10_1016_j_jaci_2021_10_034
Cites_doi 10.1073/pnas.1415357111
10.1006/anae.1995.1009
10.1371/journal.pone.0061217
10.1186/s13059-014-0550-8
10.1186/2049-2618-1-17
10.1371/journal.pbio.1001610
10.1038/nature11209
10.1073/pnas.0915056107
10.1016/j.jaci.2016.08.045
10.1128/IAI.59.6.2075-2082.1991
10.1101/gr.112730.110
10.1038/nri.2016.111
10.1128/AEM.00003-14
10.1073/pnas.1705882114
10.1128/IAI.01348-10
10.18637/jss.v059.i05
10.1186/1471-2105-9-559
10.1111/all.13232
10.1038/ni.2143
10.1084/jem.180.3.1097
10.1016/j.jaci.2011.02.026
10.1001/jama.2015.18589
10.1038/nmeth.f.303
10.1038/nature06244
ContentType Journal Article
Copyright 2018 American Academy of Allergy, Asthma & Immunology
Copyright Elsevier Limited Jul 2018
Copyright_xml – notice: 2018 American Academy of Allergy, Asthma & Immunology
– notice: Copyright Elsevier Limited Jul 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1016/j.jaci.2018.04.016
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList Entomology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 338.e9
ExternalDocumentID PMC6433125
29729303
10_1016_j_jaci_2018_04_016
S0091674918306286
Genre Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Correspondence
Letter to the Editor
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: K08 AI102945
– fundername: NHLBI NIH HHS
  grantid: T32 HL007427
– fundername: NIAID NIH HHS
  grantid: R01 AI118833
– fundername: NHLBI NIH HHS
  grantid: U01 HL091528
– fundername: NHLBI NIH HHS
  grantid: R01 HL108818
– fundername: NIAID NIH HHS
  grantid: T32 AI007306
– fundername: NHLBI NIH HHS
  grantid: R01 HL091528
– fundername: NIAMS NIH HHS
  grantid: R01 AR048632
– fundername: NIH HHS
  grantid: UH3 OD023268
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c490t-67ba97f042cb620257dc6919a0eee4ee565c2e80e6117e383438bb54e3601fb23
IEDL.DBID .~1
ISSN 0091-6749
1097-6825
IngestDate Thu Aug 21 14:11:44 EDT 2025
Mon Jul 21 09:44:03 EDT 2025
Sat Aug 23 13:12:18 EDT 2025
Mon Jul 21 05:58:29 EDT 2025
Thu Apr 24 23:10:39 EDT 2025
Tue Jul 01 00:47:36 EDT 2025
Sun Apr 06 06:53:20 EDT 2025
Tue Aug 26 16:36:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-67ba97f042cb620257dc6919a0eee4ee565c2e80e6117e383438bb54e3601fb23
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-2
content type line 14
ObjectType-Letter to the Editor-1
ObjectType-Article-2
ObjectType-Correspondence-1
content type line 23
These authors contributed equally to this work.
Current/present address: Jessica H. Savage is currently at Vertex Pharmaceuticals, Boston, Mass and Augusto A. Litonjua is at the Division of Pediatric Pulmonary Medicine, Golisano Children’s Hospital at University of Rochester Medical Center, Rochester, NY.
PMID 29729303
PQID 2063221213
PQPubID 105664
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6433125
proquest_miscellaneous_2035247813
proquest_journals_2063221213
pubmed_primary_29729303
crossref_citationtrail_10_1016_j_jaci_2018_04_016
crossref_primary_10_1016_j_jaci_2018_04_016
elsevier_sciencedirect_doi_10_1016_j_jaci_2018_04_016
elsevier_clinicalkey_doi_10_1016_j_jaci_2018_04_016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-07-01
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2018
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References McHardy, Goudarzi, Tong, Ruegger, Schwager, Weger (bib3) 2013; 1
Wieland Brown, Penaranda, Kashyap, Williams, Clardy, Kronenberg (bib7) 2013; 11
Jyonouchi, Abraham, Orange, Spergel, Gober, Dudek (bib6) 2011; 128
Turnbaugh, Turnbaugh, Ley, Ley, Hamady, Hamady (bib8) 2007; 449
Ling, Li, Liu, Cheng, Luo, Tong (bib2) 2014; 80
Yu, Freeland, Nadeau (bib1) 2016; 16
Kato, Muto, Tanaka-Bandoh, Watanabe, Ueno (bib5) 1995; 1
Litonjua, Carey, Laranjo, Harshfield, McElrath, O'Connor (bib4) 2016; 315
Litonjua (10.1016/j.jaci.2018.04.016_bib4) 2016; 315
Brennan (10.1016/j.jaci.2018.04.016_bibE15) 2011; 12
McHardy (10.1016/j.jaci.2018.04.016_bib3) 2013; 1
Zitomersky (10.1016/j.jaci.2018.04.016_bibE17) 2011; 79
Caporaso (10.1016/j.jaci.2018.04.016_bibE5) 2010; 7
Haas (10.1016/j.jaci.2018.04.016_bibE4) 2011; 21
(10.1016/j.jaci.2018.04.016_bibE3) 2012; 486
Kato (10.1016/j.jaci.2018.04.016_bib5) 1995; 1
Sordillo (10.1016/j.jaci.2018.04.016_bibE2) 2017; 139
Yu (10.1016/j.jaci.2018.04.016_bib1) 2016; 16
Love (10.1016/j.jaci.2018.04.016_bibE9) 2014; 15
Pantosti (10.1016/j.jaci.2018.04.016_bibE16) 1991; 59
Brennan (10.1016/j.jaci.2018.04.016_bibE12) 2017; 114
Tingley (10.1016/j.jaci.2018.04.016_bibE10) 2014; 59
Muindi (10.1016/j.jaci.2018.04.016_bibE14) 2010; 107
Wieland Brown (10.1016/j.jaci.2018.04.016_bib7) 2013; 11
Ling (10.1016/j.jaci.2018.04.016_bib2) 2014; 80
McMurdie (10.1016/j.jaci.2018.04.016_bibE6) 2013; 8
Turnbaugh (10.1016/j.jaci.2018.04.016_bib8) 2007; 449
Langfelder (10.1016/j.jaci.2018.04.016_bibE8) 2008; 9
Lantz (10.1016/j.jaci.2018.04.016_bibE13) 1994; 180
Evans (10.1016/j.jaci.2018.04.016_bibE7) 2014; 4
Jyonouchi (10.1016/j.jaci.2018.04.016_bib6) 2011; 128
Savage (10.1016/j.jaci.2018.04.016_bibE1) 2018; 73
Brennan (10.1016/j.jaci.2018.04.016_bibE11) 2014; 111
References_xml – volume: 1
  start-page: 17
  year: 2013
  ident: bib3
  article-title: Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships
  publication-title: Microbiome
– volume: 11
  year: 2013
  ident: bib7
  article-title: Production of  α-galactosylceramide by a prominent member of the human gut microbiota
  publication-title: PLoS Biol
– volume: 128
  start-page: 102
  year: 2011
  end-page: 109
  ident: bib6
  article-title: Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin
  publication-title: J Allergy Clin Immunol
– volume: 80
  start-page: 2546
  year: 2014
  end-page: 2554
  ident: bib2
  article-title: Altered fecal microbiota composition associated with food allergy in infants
  publication-title: Appl Environ Microbiol
– volume: 16
  start-page: 751
  year: 2016
  end-page: 765
  ident: bib1
  article-title: Food allergy: immune mechanisms, diagnosis and immunotherapy
  publication-title: Nat Rev Immunol
– volume: 449
  start-page: 804
  year: 2007
  end-page: 810
  ident: bib8
  article-title: The human microbiome project
  publication-title: Nature
– volume: 315
  start-page: 362
  year: 2016
  end-page: 370
  ident: bib4
  article-title: Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial
  publication-title: JAMA
– volume: 1
  start-page: 135
  year: 1995
  end-page: 139
  ident: bib5
  article-title: Sphingolipid composition in Bacteroides species
  publication-title: Anaerobe
– volume: 111
  start-page: 13433
  year: 2014
  ident: 10.1016/j.jaci.2018.04.016_bibE11
  article-title: Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1415357111
– volume: 1
  start-page: 135
  year: 1995
  ident: 10.1016/j.jaci.2018.04.016_bib5
  article-title: Sphingolipid composition in Bacteroides species
  publication-title: Anaerobe
  doi: 10.1006/anae.1995.1009
– volume: 4
  start-page: 1
  year: 2014
  ident: 10.1016/j.jaci.2018.04.016_bibE7
  article-title: Metabolomics: open access high resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics
  publication-title: Metabolomics
– volume: 8
  year: 2013
  ident: 10.1016/j.jaci.2018.04.016_bibE6
  article-title: Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0061217
– volume: 15
  start-page: 550
  year: 2014
  ident: 10.1016/j.jaci.2018.04.016_bibE9
  article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
  publication-title: Genome Biol
  doi: 10.1186/s13059-014-0550-8
– volume: 1
  start-page: 17
  year: 2013
  ident: 10.1016/j.jaci.2018.04.016_bib3
  article-title: Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships
  publication-title: Microbiome
  doi: 10.1186/2049-2618-1-17
– volume: 11
  year: 2013
  ident: 10.1016/j.jaci.2018.04.016_bib7
  article-title: Production of  α-galactosylceramide by a prominent member of the human gut microbiota
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.1001610
– volume: 486
  start-page: 215
  year: 2012
  ident: 10.1016/j.jaci.2018.04.016_bibE3
  article-title: A framework for human microbiome research
  publication-title: Nature
  doi: 10.1038/nature11209
– volume: 107
  start-page: 3052
  year: 2010
  ident: 10.1016/j.jaci.2018.04.016_bibE14
  article-title: Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0915056107
– volume: 139
  start-page: 482
  year: 2017
  ident: 10.1016/j.jaci.2018.04.016_bibE2
  article-title: Factors influencing the infant gut microbiome at age 3-6 months: findings from the ethnically diverse Vitamin D Antenatal Asthma Reduction Trial (VDAART)
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.08.045
– volume: 59
  start-page: 2075
  year: 1991
  ident: 10.1016/j.jaci.2018.04.016_bibE16
  article-title: Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis
  publication-title: Infect Immun
  doi: 10.1128/IAI.59.6.2075-2082.1991
– volume: 21
  start-page: 494
  year: 2011
  ident: 10.1016/j.jaci.2018.04.016_bibE4
  article-title: Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
  publication-title: Genome Res
  doi: 10.1101/gr.112730.110
– volume: 16
  start-page: 751
  year: 2016
  ident: 10.1016/j.jaci.2018.04.016_bib1
  article-title: Food allergy: immune mechanisms, diagnosis and immunotherapy
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.111
– volume: 80
  start-page: 2546
  year: 2014
  ident: 10.1016/j.jaci.2018.04.016_bib2
  article-title: Altered fecal microbiota composition associated with food allergy in infants
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.00003-14
– volume: 114
  start-page: 8348
  year: 2017
  ident: 10.1016/j.jaci.2018.04.016_bibE12
  article-title: Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1705882114
– volume: 79
  start-page: 2012
  year: 2011
  ident: 10.1016/j.jaci.2018.04.016_bibE17
  article-title: Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut
  publication-title: Infect Immun
  doi: 10.1128/IAI.01348-10
– volume: 59
  start-page: 1
  year: 2014
  ident: 10.1016/j.jaci.2018.04.016_bibE10
  article-title: Mediation: R Package for Causal Mediation Analysis
  publication-title: J Stat Softw
  doi: 10.18637/jss.v059.i05
– volume: 9
  start-page: 559
  year: 2008
  ident: 10.1016/j.jaci.2018.04.016_bibE8
  article-title: an R package for weighted correlation network analysis
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-9-559
– volume: 73
  start-page: 145
  year: 2018
  ident: 10.1016/j.jaci.2018.04.016_bibE1
  article-title: A prospective microbiome-wide association study of food sensitization and food allergy in early childhood
  publication-title: Allergy
  doi: 10.1111/all.13232
– volume: 12
  start-page: 1202
  year: 2011
  ident: 10.1016/j.jaci.2018.04.016_bibE15
  article-title: Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals
  publication-title: Nat Immunol
  doi: 10.1038/ni.2143
– volume: 180
  start-page: 1097
  year: 1994
  ident: 10.1016/j.jaci.2018.04.016_bibE13
  article-title: An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8− T cells in mice and humans
  publication-title: J Exp Med
  doi: 10.1084/jem.180.3.1097
– volume: 128
  start-page: 102
  year: 2011
  ident: 10.1016/j.jaci.2018.04.016_bib6
  article-title: Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.02.026
– volume: 315
  start-page: 362
  year: 2016
  ident: 10.1016/j.jaci.2018.04.016_bib4
  article-title: Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2015.18589
– volume: 7
  start-page: 335
  year: 2010
  ident: 10.1016/j.jaci.2018.04.016_bibE5
  article-title: QIIME allows analysis of high-throughput community sequencing data
  publication-title: Nat Methods
  doi: 10.1038/nmeth.f.303
– volume: 449
  start-page: 804
  year: 2007
  ident: 10.1016/j.jaci.2018.04.016_bib8
  article-title: The human microbiome project
  publication-title: Nature
  doi: 10.1038/nature06244
SSID ssj0009389
Score 2.4635942
Snippet [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 335
SubjectTerms Age
Antigens
Asthma
Bacteroides
Bacteroides fragilis - metabolism
Cesarean section
Child, Preschool
Children
Eigenvalues
Feces
Female
Food allergies
Food Hypersensitivity - immunology
Food Hypersensitivity - metabolism
Food Hypersensitivity - microbiology
Gastrointestinal Microbiome - immunology
Genotype & phenotype
Humans
Hypotheses
Infant
Intestine
Lipids
Male
Mediation
Metabolites
Natural Killer T-Cells - immunology
Pruritus
Sphingolipids
Sphingolipids - immunology
Sphingolipids - metabolism
Title Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergy
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674918306286
https://dx.doi.org/10.1016/j.jaci.2018.04.016
https://www.ncbi.nlm.nih.gov/pubmed/29729303
https://www.proquest.com/docview/2063221213
https://www.proquest.com/docview/2035247813
https://pubmed.ncbi.nlm.nih.gov/PMC6433125
Volume 142
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KBfFF_PZsLRF8k9hLstmPx1Isp9I-WejbsruZaMo1d9xdhb74t3cm2URPpYIvgWRnQzKZmf3t5jezAG8zraXXQaayUpgKo4tUCwxpXilFA1wthefc4dMzOTsXny7Kix04HnJhmFYZY38f07toHa8cRm0eLpuGc3wNU-gNGSUnAnLZbSEUW_n7Hz9pHqbQPQQ2WcrSMXGm53hdutAwvUt35U55z_O_D05_gs_fOZS_DEonj-BhRJPJUf_Aj2EH2ydw_zT-L38Klhf8yIlZ6Krpai65eVqR1X3HKlkveflpMW-WTbVO3AqTpmWWBs5vEhc_G4nxUm0ShhLISc0H3oFl9fXmGZyffPhyPEvjlgppEGa6IQ14Z1RNnhq8zAnvqCpIkxk3RUSBSPAu5KinKLNMIc1eRaG9LwUWNHGrfV48h9120eJLSPLc1YS1QikrR46vvaA7-iLzLmijTDaBbNClDbHeOG97MbcDsezSsv4t699OhaVLE3g39ln21TbulC6GT2SHPFKKfJYGgzt7lWOvLUv7Z7_9wQps9PM1tUuKiFwWbwJvxmbyUP7t4lpcXLMMgVzO6CWZF73RjC-XG5rcEIqYgNoyp1GAq39vt7TNt64KuORct7x89Z-vswcP-KxnHu_D7mZ1ja8JX238QedAB3Dv6OPn2dktE3klfQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NTgJeEL_pGBAk3lC0JnEc-3GamDq29mmT9mbZzgUydWnVdkj773fXOIECGhIvfYjvouZyd_7s3H0G-JQoJZ3yMpZlgbHQKouVQB-nZVHQBFdJ4bh3eDKV4wvx9TK_3IGjrheGyypD7m9z-iZbhysHwZoHi7rmHl_NJfSanJIbAeUD2GV2qnwAu4cnp-PpT-7dTLUoWCcxK4TembbM68r6miu81IbxlI89__v89Cf-_L2M8pd56fgpPAmAMjps__Mz2MHmOTychE_mL8Dwnh_FMQtd1xvaJTuLS3K8H1hGqwXvQM1n9aIuV5FdYlQ3XKiBs9vIhjdHYrxbG_mOBTmq-IcPYVl-u30JF8dfzo_GcThVIfZCj9ZkAWd1UVGweidTgjxF6aVOtB0hokAkhOdTVCOUSVIgLWBFppzLBWa0dqtcmr2CQTNv8A1EaWorgls-l6Wl2FdO0B1dljjrlS50MoSks6XxgXKcT76Yma627Mqw_Q3b34yEoUtD-NzrLFrCjXuls-4Vma6VlJKfofngXq2819pytn_q7XdeYEKor2hcUlJkZrwhfOyHKUj5y4ttcH7DMoRzuamXZF63TtM_XKppfUNAYgjFljv1AkwAvj3S1N83ROCS293SfO8_H-cDPBqfT87M2cn09C085pG2EHkfBuvlDb4juLV270M43QEI7ygu
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intestinal+microbial-derived+sphingolipids+are+inversely+associated+with+childhood+food+allergy&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Lee-Sarwar%2C+Kathleen&rft.au=Kelly%2C+Rachel+S&rft.au=Lasky-Su%2C+Jessica&rft.au=D+Branch+Moody&rft.date=2018-07-01&rft.pub=Elsevier+Limited&rft.issn=0091-6749&rft.eissn=1097-6825&rft.volume=142&rft.issue=1&rft.spage=335&rft_id=info:doi/10.1016%2Fj.jaci.2018.04.016&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon